Idenix Pharmaceuticals, Inc. (IDIX) Reports Third Quarter and Nine Month 2013 Financial Results and Provides HCV Pipeline Update
10/31/2013 10:16:05 AM
CAMBRIDGE, Mass., Oct. 30, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the third quarter ended September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by